highly differentiated pharmaceutical company. I look forward to all that we will accomplish as we grow globally and embrace new opportunities, driven by our purpose." The acquisition follows a ...

Explore Q1 2025's biotech stock moves, from CervoMed's 300% surge to Septerna's struggles. Click for my review of the quarter ...

Patient centricity has rapidly gone from a fringe idea to a fundamental principle across the industry, but are pharma companies missing ... patient organisations are front-line for patient support.

As identified in our 10-K, we've accepted nonbinding potential terms from a commercial pharmaceutical company to license ... known to jump off roofs and in front of oncoming trains.

An editorial on how to cut health care costs stirred readers to offer solutions of their own, from pushing for a single-payer ...

Getting a clear view of which companies are really 'walking the talk' in pharma and delivering meaningful ... company remains a leader in front-line therapy in type 1 diabetes and has a ...

Roche is expanding its scope to a promising but competitive new obesity target, committing $1.65 billion up front to partner on a clinical-stage Zealand Pharma ... calls for the companies to ...

Shares in Coles and Woolworths surged on Friday, after a report into the supermarket sector. Investors seemed to cheer the findings, with analysts describing it as a "relief rally" for the stocks.

Pete Hegseth's review could shake things up During an appearance with Martin in front of reporters ... Ireland's single biggest export market for pharmaceutical drugs and ingredients, mostly ...

Indian pharma stocks were in focus on Thursday (April 3, 2025) early trading hours after the generic drugmakers got an exemption from U.S. tariff levy. Also read: Front-end manufacturing in U.S ...

Major pharmaceutical companies reap most of their profits in the U.S. but shift their tax burdens to low-tax havens such as ...

What to do? Within our space, the companies facing this decision are typically large pharmaceutical organizations—household names like Pfizer, GSK and Novartis. For these companies, there are a ...